Targeting GPVI and CLEC-2 with fostamatinib as a novel antithrombotic strategy

Thomas, Mark R (Principal Investigator)
Nicolson, Pip (Co-Investigator)
Watson, Steve (Co-Investigator)

Short title	Targeting GPVI and CLEC-2 with fostamatinib as a novel antithrombotic strategy
Status	Finished
Effective start/end date	1/12/18 → 31/12/23

Funding

RIGEL PHARMACEUTICALS INC

Antithrombotic effects of fostamatinib in combination with conventional antiplatelet drugs
Harbi, M., Smith, C., Alenazy, F., Nicolson, P., Tiwari, A., Watson, S. & Thomas, M. R., 23 Jun 2022, (E-pub ahead of print) In: International Journal of Molecular Sciences. 23, 13, 17 p., 6982.
Research output: Contribution to journal › Article › peer-review

Open Access
File
86 Downloads (Pure)